Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development Conference
Authors: Sol Sherry, William R. Bell, F. H. Duckert, Anthony P. Fletcher, Victor Gurewich, David M. Long, Victor J. Marder, Harold Roberts, Edwin W. Salzman, Arthur Sasahara, Marc Verstraete
Journal: Annals of Internal Medicine (1980)

Symposium1 July 1980Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development ConferenceSOL SHERRY, WILLIAM R. BELL, F. H. DUCKERT, ANTHONY P. FLETCHER, VICTOR GUREWICH, DAVID M. LONG, VICTOR J. MARDER, HAROLD ROBERTS, EDWIN W. SALZMAN, ARTHUR SASAHARA, MARC VERSTRAETESOL SHERRY, WILLIAM R. BELL, F. H. DUCKERT, ANTHONY P. FLETCHER, VICTOR GUREWICH, DAVID M. LONG, VICTOR J. MARDER, HAROLD ROBERTS, EDWIN W. SALZMAN, ARTHUR SASAHARA, MARC VERSTRAETEAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-93-1-141 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFor over three decades, the primary method of therapy used by almost all physicians for the management of acute deep-vein thrombosis and pulmonary embolism has been anticoagulation. This form of therapy has become so ingrained in medical practice that physicians, although still concerned over the bleeding risk associated with the use of anticoagulants, nevertheless seem secure in the belief that they are providing optimal, if not ideal, therapy for these disorders. With the advent of thrombolytic therapy (the thrombolytic agents considered at this conference were urokinase and streptokinase), this is no longer true for many cases. Anticoagulation for the management... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByUltrasound-Accelerated, Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism: Single-Center Retrospective Review with Intermediate-Term OutcomesPulmonary Artery Thrombectomy and ThrombolysisTranscatheter Renal Interventions: A Review of Established and Emerging ProceduresImprovements in Pulmonary Artery Pressure and Right Ventricular Function After Ultrasound-Accelerated Catheter-Directed Thrombolysis for the Treatment of Pulmonary EmbolismEfficacy and Safety of Flow-Directed Pulmonary Artery Catheter Thrombolysis for Treatment of Submassive Pulmonary EmbolismUpdate on stroke managementThrombolytic TherapyIntravenous Thrombolytics for Ischemic StrokeThe effect of the fibrinolytic enzyme FIIa from Agkistrodon acutus venom on acute pulmonary thromboembolismDer reanimierte Patient mit frischem Herzinfarkt – Thrombolyse oder Herzkatheter?Thrombolytic therapy for deep vein thrombosis: potential application of plasminVorgehen bei STEMI/NSTEMI nach ReanimationDeep Vein Thrombosis of Lower Extremity: Direct Intraclot Injection of Alteplase Once Daily with Systemic Anticoagulation—Results of Pilot StudyThrombolytic TherapyPulsed High-Intensity Focused Ultrasound Enhances Thrombolysis in an in Vitro ModelMechanical Thrombectomy of Acute Iliofemoral Deep Vein Thrombosis with Use of an Arrow-Trerotola Percutaneous Thrombectomy DeviceThrombolytic treatment of acute pulmonary embolism in myotonic dystrophyTissue plasminogen activator in peripheral arterial thrombolysisAcute limb ischaemia: The place of intravenous streptokinaseThrombolytic therapy in the management of acute limb ischaemiaRandomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysisAcute lower limb ischaemiaLocal low dose intra-arterial thrombolytic therapy: The risk of stroke or major haemorrhageEndoluminal Recanalization in a Patient with Phlegmasia Cerulea Dolens Using a Multimodality ApproachACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionAcute pulmonary embolismCatheter-Directed Thrombolysis for Deep Venous ThrombosisRisk Factors for Venous ThromboembolismDistinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageSequential use of thrombolytic agents for thrombosed mitral valve prosthesis during pregnancyUse of Thrombolytic Therapy to Treat Heparin-Refractory Pulmonary Embolism in a Menstruating PatientThrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: A reviewThrombolytic therapy: 2001Out-of-hospital thrombolysis in cardiac arrest after unsuccessful resuscitationDaily Catheter-directed Single Dosing of t-PA in Treatment of Acute Deep Venous Thrombosis of the Lower ExtremityDeep Venous ThrombosisStreptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator ComplexFármacos fibrinolíticosCardiac Arrest and the Role of Thrombolytic AgentsPulmonary embolism—an update on thrombolytic therapyTHROMBOLYTIC THERAPYThrombolytic Therapy of Pulmonary EmbolismInvasive lumeneröffnende TherapiePerceived contraindications to thrombolytic treatment in acute myocardial infarction. A survey at a teaching hospital.Invasive lumeneröffnende TherapieComparaison de l'efficacité et de la tolérance d'un traitement thrombolytique par rt-PA dans l'embolie pulmonaire aiguë massive chez le sujet âgé et chez les moins de 75 ansPulmonary embolism from axillosubclavian thrombosis on a rehabilitation unit: Case reportMulticenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosisTherapeutic Decisions Involving Disparate Clinical OutcomesThrombolysis for acute pulmonary embolism: Are the risks worth the benefits?Pulmonary embolism--the role of thrombolytic therapy in its management.Clinical Presentation and Results of Thrombolytic Therapy in Older Patients with Massive Pulmonary Embolism: A Comparison with Non-Elderly PatientsSpontaneous Spinal Epidural Hematoma After Combined Urokinase and Heparin Thrombolytic Therapy for Deep Venous ThrombosisHemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous ThromboembolismUse of Thrombolytics for the Treatment of Thromboembolic Disease During PregnancyVENOUS THROMBOEMBOLISMEstrategia terapéutica en la enfermedad tromboembólica venosa (ETV)MASSIVE PULMONARY EMBOLISMPercutaneous aspiration thromboembolectomy: A preliminary experienceA Decision Analysis of Streptokinase plus Heparin as Compared with Heparin Alone for Deep-Vein ThrombosisIncorporating Patients' Preferences into Medical DecisionsPulmonary Embolism in the Intensive Care UnitThrombolytic Therapy in Elderly PatientsIntravenous thrombolysisBleeding DisordersAcute Renal Allograft Dysfunction in the Setting of Deep Venous Thrombosis: A Case of Successful Urokinase Thrombolysis and a Review of the LiteratureA simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this modelIntracranial Hemorrhage as the Synergistic Effect of Urokinase and Renal Dysfunction—A Case ReportThrombolytic Therapy: A Comprehensive Review of Its Use in Clinical Medicine. Part IITiefe venöse Thrombosen — etablierte Behandlungsverfahren und neue TrendsPhysician practices in the management of venous thromboembolism: A community-wide surveyHemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous ThromboembolismTreatment of Massive Pulmonary Thromboembolism with Low Intrapulmonary Dosages of UrokinaseThrombosed Central Venous Catheters: Restoring Function With 6-Hour Urokinase Infusion After Failure of Bolus UrokinaseHemorrhagic infarct conversion in experimental strokeThrombosisDisorders of HaemostasisMechanisms of fibrinolysis and clinical use of thrombolytic agentsAnticoagulants, Antithrombotic and Thrombolytic AgentsPerkutane transluminale Angioplastie (PTA)Kathetervermittelte lokale Fibrinolysetherapie (LFT)Managing Pulmonary EmbolismThrombolytic therapy for noncoronary diseasesIntracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.Modern treatment of pulmonary embolismFatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg?Use of plasminogen activators in venous thrombosisThrombolysis in deep venous thrombosis11 Thrombolytic therapy for venous thromboembolismDeep venous thrombosis of the upper extremity: Diagnosis and treatmentFuture role of thrombolytic therapy in emergency medicineMassive pulmonary embolismPulmonary EmbolismSelection of Patients with Acute Pulmonary Embolism for Thrombolytic TherapyTissue Plasminogen Activator in Acute Pulmonary EmbolismPractical use of AnticoagulantsAcute Closed-Angle Glaucoma Complicating Hemorrhagic Choroidal Detachment Associated with Parenteral Thrombolytic AgentsUrokinase Efficacy for Deep Vein Thrombosis Developing During Streptokinase Therapy—A Case ReportThrombolytic Therapy: Current StatusSpontaneous Subclavian Vein ThrombosisPulmonary EmbolismRecent Advances in the Management of Venous ThromboembolismPulmonary embolismThrombolytic Agents for Acute Myocardial InfarctionDeep Venous Thrombosis of the Upper LimbsChronic Primary and Secondary Thromboembolic Pulmonary HypertensionCoronary ThrombolysisThrombolytic Therapy in Acute Myocardial Infarction: Part IHemorrhagic and Thrombotic Abnormalities of CancerSuccessful Treatment of Superior Vena Cava Syndrome with Urokinase in an InfantThrombolytic therapy of acute pulmonary embolism: Current status and future potentialAdverse Reactions to Thrombolytic AgentsReview: Thrombolytic Therapy for Patients with Acute Myocardial InfarctionThe Fibrinolytic System and Its Pharmacologic Activation for ThrombolysisLysis of Venous, Pulmonary, Prosthetic Valvular, Arterial, and Ventricular ClotsCoronary Thrombolysis: Practical ConsiderationsUse of streptokinase for the salvage of a free flap: Case report and review of the use of thrombolytic therapyMassive Pulmonary Embolism: Short-Term Effects of Thrombolytic TreatmentComparison of fibrinolytic treatment with interruption of the inferior caval vein in the prevention of pulmonary embolismCardiogenic and Hypovolemic ShockPulmonary EmbolismTreatment of Venous ThromboembolismStreptokinase Therapy in the Routine Management of Deep Venous Thrombosis in the Lower ExtremitiesPulmonary thromboembolic diseaseMechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapyThrombolytic Therapy for Superior Vena Caval Thrombosis Following Superior Vena Cava–Pulmonary Artery AnastomosisThe Postphlebitic SyndromeTo the EditorRecent advances using streptokinase for acute coronary thrombosisIntraarterial infusion of low-dose streptokinase after acute thromboembolization of the right renal arteryPulmonary Emboli with Respiratory FailureLow Dose Thrombolysis: A Nonoperative Approach to Renal Artery OcclusionPost Embolectomy Thrombosis Treated with Intra-Arterial StreptokinaseThe Respiratory SystemInferior Vena Cava Interruption in the Management of Pulmonary EmbolismSymptomatic venous thrombosis of the upper extremity complicating permanent transvenous pacing: Reversal with streptokinase infusionUpper Extremity Thrombosis: Etiology and PrognosisTask force IV: Pharmacologie interventionsSubcutaneous Heparin for Venous ThrombosisThrombolytic Therapy in Severe Arterial Insufficiency With Absent Distal PulsesPulmonary disordersMassive fatal pulmonary emboli with fibrinolytic therapy.Consensus StatementsPulmonary embolism in childrenThrombolytic TherapySTANLEY L. SCHRIER, M.D.Are We Using Fibrinolytic Agents Often Enough?VICTOR J. MARDER, M.D. 1 July 1980Volume 93, Issue 1_Part_1Page: 141-144KeywordsAnticoagulant therapyAnticoagulantsHemorrhagePulmonary embolismThrombosis Issue Published: 1 July 1980 PDF DownloadLoading ...